VALYSTR · Stock research
Listed on NYSE. What the market is pricing into Edwards Lifesciences (EW) in the Healthcare sector: implied growth, valuation scenarios, SEC-filed financials, and what has moved the stock.
Healthcare · Medical Specialties · market value about $54.8B · P/E 54.7 · revenue $6.5B (as of 2026-11-04)
Opening the full page… All companies · Research guides · What a reverse DCF shows